There is no doubt about the crucial role of PD-L1 expression status in predicting the checkpoint inhibitor response and prognosis in patients with NSCLC, but few studies have linked radiomics features extracted from pretreatment CT to the prediction of PD-L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.